Glenmark Pharma
BSE: 532296|NSE: GLENMARK|ISIN: INE935A01035|SECTOR: Pharmaceuticals
352.20
-4.1 (-1.15%)
VOLUME 42,114
352.80
-2.15 (-0.61%)
VOLUME 590,212
| Raw Materials |
------------------- in Rs. Cr. ------------------- |
Mar 2011 |
| Product Name |
Unit |
Quantity |
Value |
| Others |
Not Reported |
NA |
194.91 |
| Telmisartan |
Kgs |
8,897 |
7.96 |
| Bottles (PET) |
Numbers |
31,202,724 |
5.47 |
| Sugar |
Kgs |
1,763,619 |
5.44 |
| Mupirocin |
Kgs |
376 |
5.34 |
| Linezolid |
Kgs |
2,374 |
4.06 |
| Propylene Glycol |
Kgs |
387,926 |
3.87 |
| Sorbitol 70% Solution IP |
Kgs |
870,701 |
3.01 |
| Cefuroxime Axetil |
Kgs |
2,733 |
2.83 |
| Other Raw Materials |
Kgs |
436 |
2.67 |
| Clarithromycin |
Kgs |
1,946 |
2.43 |
|
|
|
| Total |
|
237.99 |
 |
| Source : Dion Global Solutions Limited |
 |
Quick Links for glenmarkpharma
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.